ANTIBIOTIC RESISTANCE PATTERNS IN BACTERIAL DERMATOLOGICAL INFECTIONS: A CROSS-SECTIONAL STUDY FROM A TERTIARY CARE HOSPITAL IN NORTH INDIA

Main Article Content

Dr Rashi Pangti
Dr Nidhi Paliwal
Dr Radha Sharma
Dr Jatin Prajapati

Keywords

Antibiotic resistance; Dermatological infections; MRSA; Multidrug resistance; North India; Antimicrobial stewardship

Abstract

Background: Antibiotic resistance among dermatological infections is an emerging concern, particularly in developing countries like India where antibiotic misuse is prevalent. Understanding local resistance patterns is crucial for effective management and prevention of complications.


Objectives: To identify the common bacterial pathogens causing dermatological infections and to evaluate their antibiotic resistance patterns in a tertiary care hospital in North India.


Methods: A hospital-based cross-sectional observational study was conducted from January 2022 to August 2022, including 180 patients with clinically diagnosed bacterial skin infections. Samples were collected and processed using standard microbiological techniques. Antibiotic susceptibility testing was performed using the Kirby–Bauer disc diffusion method as per CLSI 2016 guidelines. Data were analyzed using SPSS version 20.0, and a p-value <0.05 was considered statistically significant.


Results: The majority of patients were in the 21–40 years age group, with a male predominance. Folliculitis was the most common clinical presentation. Staphylococcus aureus was the predominant isolate, accounting for over half of the cases, with 15.6% identified as MRSA. Gram-negative organisms such as Escherichia coli and Pseudomonas aeruginosa were also observed. High resistance to penicillin and moderate resistance to erythromycin and ciprofloxacin were noted among S. aureus isolates, while linezolid and vancomycin showed high sensitivity. Multidrug resistance was observed in 32.2% of isolates. A statistically significant association was found between MRSA and recurrent infections (p < 0.05).


Conclusion: The study demonstrates a significant prevalence of antibiotic resistance in dermatological infections, highlighting the need for rational antibiotic use and regular surveillance. Local antibiograms should guide empirical therapy, and antimicrobial stewardship programs must be strengthened to combat resistance.

Abstract 0 | pdf Downloads 0

References

1. World Health Organization. Antimicrobial resistance: global report on surveillance 2014.
2. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C. Antibiotic resistance—the need for global solutions. The Lancet infectious diseases. 2013 Dec 1;13(12):1057-98.
3. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and therapeutics. 2015 Apr;40(4):277.
4. Dryden MS. Skin and soft tissue infection: microbiology and epidemiology. International journal of antimicrobial agents. 2009 Jul 1;34:S2-7.
5. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clinical infectious diseases. 2014 Jul 15;59(2):e10-52.
6. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clinical microbiology reviews. 2010 Jul;23(3):616-87.
7. Chandy SJ, Thomas K, Mathai E, Antonisamy B, Holloway KA, Stalsby Lundborg C. Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India. J Antimicrob Chemother. 2013 Jan;68(1):229-36.
8. Rajaduraipandi K, Mani KR, Panneerselvam K, Mani M, Bhaskar M, Manikandan P. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus: A multicentre study. Indian journal of medical microbiology. 2006 Jan 1;24(1):34-8.
9. CLSI. Performance standards for antimicrobial susceptibility testing. 26th ed. 2016.
10. Gandra S, Mojica N, Klein EY, Ashok A, Nerurkar V, Kumari M, Ramesh U, Dey S, Vadwai V, Das BR, Laxminarayan R. Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014. Int J Infect Dis. 2016 Sep;50:75-82.
11. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler Jr VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clinical microbiology reviews. 2015 Jul;28(3):603-61.
12. Tiwari HK, Sapkota D, Sen MR. High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India. Infection and drug resistance. 2008 Nov 30:57-61.
13. Kaur DC, Chate SS. Study of antibiotic resistance pattern in methicillin-resistant Staphylococcus aureus with special reference to newer antibiotics. J Glob Infect Dis. 2015;7(2):78–84.
14. Basak S, Singh P, Rajurkar M. Multidrug resistant and extensively drug resistant bacteria: a study. Journal of pathogens. 2016;2016(1):4065603.

Most read articles by the same author(s)

1 2 > >>